Our Vision is to Create a Healthier World for All People
Inclusion is one of Gilead’s core values — it helps us understand how our treatments will uniquely affect different types of patients. We’re actively working to include a diverse group of participants across all our clinical trials, thereby promoting the development of medical knowledge.
Our Therapeutic Leadership
For 35 years, Gilead has discovered, developed and delivered innovative therapies in areas of great unmet need. We helped transform HIV from a fatal disease to one that can be well managed, and we’ve helped cure millions of people with hepatitis C around the world. Our decades of research in emerging viruses allowed us to deliver the first approved treatment for COVID-19. And together with Kite, a Gilead Company, which is focused on cell therapy, we’re making an impact in multiple types of cancer.
Known for our commitment to innovation and access, we are poised to meet our ambition, set in 2019, to deliver 10+ transformative therapies by 2030.
.jpg?h=410&iar=0&w=384&hash=FC33D4E9EDDB0BF049E9FE48D19C2D8D)